Skip to main content
logo
Stryker Corporation (SYK)
NYSE: SYK · Real-Time Price · USD
313.22
+6.46 (2.11%)
At close: May 18, 2026, 4:00 PM EDT
313.23
+0.01 (0.00%)
After-hours: May 18, 2026, 7:45 PM EDT

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Instruments Revenue (Pre FY-2026 Reporting)
-3.18B2.83B
Instruments Revenue (Pre FY-2026 Reporting) Growth
-12.31%11.84%
Endoscopy Revenue
3.81B3.81B3.39B
Endoscopy Revenue Growth
0.03%12.33%10.46%
Medical Revenue
4.16B4.20B3.85B
Medical Revenue Growth
-1.02%9.14%11.36%
Neurovascular Revenue
2.08B1.97B1.31B
Neurovascular Revenue Growth
5.64%50.57%6.61%
Neuro Cranial Revenue
-2.49B2.14B
Neuro Cranial Revenue Growth
-16.34%13.86%
MedSurg & Neurotechnology Revenue
15.34B15.65B13.52B
MedSurg & Neurotechnology Revenue Growth
-1.94%15.75%11.14%
Knees Revenue
2.69B2.66B2.45B
Knees Revenue Growth
1.17%8.54%7.66%
Hips Revenue
1.88B1.87B1.70B
Hips Revenue Growth
0.91%9.45%10.36%
Trauma and Extremities Revenue
4.04B3.95B3.51B
Trauma and Extremities Revenue Growth
2.28%12.57%11.44%
Spinal Implants Revenue
21.00M185.00M707.00M
Spinal Implants Revenue Growth
-88.65%-73.83%-0.84%
Other Orthopaedics Revenue
-815.00M712.00M
Other Orthopaedics Revenue Growth
-14.47%8.21%
Orthopaedics Revenue
9.93B9.47B9.08B
Orthopaedics Revenue Growth
4.84%4.32%8.90%
Revenue (Other)
-18.68B-25.12B-22.60B
Revenue (Total)
25.27B25.12B22.60B
Revenue (Total) Growth
0.61%11.16%10.23%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
19.04B19.01B16.94B
United States Revenue Growth
0.19%12.18%11.05%
International Revenue
6.23B6.11B5.65B
International Revenue Growth
1.93%8.10%7.84%
Revenue (Total)
25.27B25.12B22.60B
Revenue (Total) Growth
0.61%11.16%10.23%

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
MedSurg & Neurotechnology Operating Income
4.40B4.67B4.00B
MedSurg & Neurotechnology Operating Income Growth
-5.78%16.68%15.39%
Orthopaedics Operating Income
3.03B2.82B2.59B
Orthopaedics Operating Income Growth
7.27%8.84%14.39%
Operating Income (Other)
-2.44B-2.60B-2.91B
Operating Income (Total)
4.99B4.89B3.69B
Operating Income (Total) Growth
2.02%32.53%-5.12%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Organic Net Sales Growth
10.30%10.20%
Updated May 11, 2026. Data Source: Fiscal.ai.